- Home
- PDSB vs HHS Comparison
PDSB vs HHS Comparison
Compare PDSB & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- HHS
- Stock Information
- Founded
- PDSB 2005
- HHS 1923
- Country
- PDSB United States
- HHS United States
- Employees
- PDSB N/A
- HHS N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- HHS Advertising
- Sector
- PDSB Health Care
- HHS Consumer Discretionary
- Exchange
- PDSB Nasdaq
- HHS Nasdaq
- Market Cap
- PDSB 43.1M
- HHS 37.0M
- IPO Year
- PDSB N/A
- HHS N/A
- Fundamental
- Price
- PDSB $1.25
- HHS $4.65
- Analyst Decision
- PDSB Strong Buy
- HHS
- Analyst Count
- PDSB 3
- HHS 0
- Target Price
- PDSB $10.00
- HHS N/A
- AVG Volume (30 Days)
- PDSB 275.1K
- HHS 24.5K
- Earning Date
- PDSB 05-14-2025
- HHS 05-08-2025
- Dividend Yield
- PDSB N/A
- HHS N/A
- EPS Growth
- PDSB N/A
- HHS N/A
- EPS
- PDSB N/A
- HHS N/A
- Revenue
- PDSB N/A
- HHS $185,242,000.00
- Revenue This Year
- PDSB N/A
- HHS $6.54
- Revenue Next Year
- PDSB N/A
- HHS N/A
- P/E Ratio
- PDSB N/A
- HHS N/A
- Revenue Growth
- PDSB N/A
- HHS N/A
- 52 Week Low
- PDSB $0.85
- HHS $4.27
- 52 Week High
- PDSB $4.42
- HHS $8.87
- Technical
- Relative Strength Index (RSI)
- PDSB 55.58
- HHS 49.51
- Support Level
- PDSB $1.00
- HHS $4.30
- Resistance Level
- PDSB $1.17
- HHS $4.80
- Average True Range (ATR)
- PDSB 0.11
- HHS 0.35
- MACD
- PDSB 0.04
- HHS 0.02
- Stochastic Oscillator
- PDSB 81.61
- HHS 63.33
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.